3 tips to help hospital executives tackle the pandemic-induced surgery backlog

As hospital leaders attempt to tackle the backlog of surgeries brought on by the pandemic, experts are offering a few words of advice.

Michigan Medicine medical doctors recently detailed their tips in the Annals of Surgery. They recommend that leaders get started on this work right away to avoid any harmful delays to patient treatment.

“It should be noted that, if many of these surgeries continue to be put off, many of these health conditions will continue to progress and could cause the patient to become sicker," Jessica Billig, MD, a resident physician of plastic surgery at Michigan Medicine and lead author of the paper, said Monday. “We hope these strategies offer our colleagues across the country some thoughts to consider so we can accommodate the patients that need our surgical care.”

Here's a quick look at their advice. You can read the rest of the piece in the American Surgical Association’s official publication here.

1. Continue to grow telemedicine by more broadly adopting the way in which providers are using telehealth appointments for post-operative care, including expanding virtual visits to initial surgical consultations.

2. Expand capacity by extending the operating room schedule outside of regular work hours and accommodating more appointments at ambulatory surgery centers. Clinicians can also perform minor procedures in the clinic setting to help further free up space for more complex surgeries.

3. Be transparent with patients about billing, providing detailed and upfront information about the cost of care. Many patients are experiencing monetary challenges amid the pandemic and getting upstream of these concerns can help head off cancelations. Providers should also try to schedule procedures in locations that charge the lowest out-of-pocket expense.

Marty Stempniak

Marty Stempniak has covered healthcare since 2012, with his byline appearing in the American Hospital Association's member magazine, Modern Healthcare and McKnight's. Prior to that, he wrote about village government and local business for his hometown newspaper in Oak Park, Illinois. He won a Peter Lisagor and Gold EXCEL awards in 2017 for his coverage of the opioid epidemic. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.